Jacques F. Legier
Jacques F. Legier publishes mostly in Pulmonary and Respiratory Medicine, Surgery and Oncology, on topics such as Medical Imaging and Pathology Studies, Occupational and environmental lung diseases and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis.
- World rank
- #2,878,574 of 7,710,434 ranked researchers
- Rank in United States
- #831,724 of 1,627,098
- Works
- 21
- Citations
- 638
- Citations per work
- 30.4
What does Jacques F. Legier research?
Jacques F. Legier's work is mostly in Medicine (72%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1572.2%
- Medicine1572.2%
- Everything else627.8%
- 1Pulmonary and Respiratory Medicine33% of their works
- 2Surgery12% of their works
- 3Oncology12% of their works
- 4Epidemiology8% of their works
- 5Rheumatology5% of their works
- 6Pathology and Forensic Medicine3% of their works
Research topics
- Medical Imaging and Pathology Studies
- Occupational and environmental lung diseases
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Full-Duplex Wireless Communications
- Pneumonia and Respiratory Infections
- Cancer Diagnosis and Treatment
- Polyomavirus and related diseases
- Sarcoma Diagnosis and Treatment
Which keywords describe Jacques F. Legier's research?
The keywords of their largest research topics: Pulmonary Alveolar Microlithiasis, Pulmonary Sclerosing Hemangioma, BAP1 mutations, Clinical Practice Guidelines, Malignant Pleural Mesothelioma, Fibrosis, Idiopathic Pulmonary Fibrosis and Cancer of Unknown Primary.
- Soft Tissue Sarcoma
- Pneumococcal Conjugate Vaccine
- Metastasis
- Full-Duplex
- Cancer of Unknown Primary
- Fibrosis
- Clinical Practice Guidelines
- Pulmonary Sclerosing Hemangioma
- Pulmonary Alveolar Microlithiasis
- BAP1 mutations
- Malignant Pleural Mesothelioma
- Idiopathic Pulmonary Fibrosis
- Community-Acquired Pneumonia
- Merkel Cell Carcinoma
- Osteosarcoma
- Polyomavirus
- Wireless Communication
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Pulmonary Alveolar Microlithiasis51 topic
- Pulmonary Sclerosing Hemangioma51 topic
- BAP1 mutations41 topic
- Clinical Practice Guidelines42 topics
- Malignant Pleural Mesothelioma41 topic
- Fibrosis31 topic
- Idiopathic Pulmonary Fibrosis31 topic
- Cancer of Unknown Primary21 topic
- Community-Acquired Pneumonia21 topic
- Full-Duplex21 topic
- Merkel Cell Carcinoma21 topic
- Metastasis21 topic
- Osteosarcoma21 topic
- Pneumococcal Conjugate Vaccine21 topic
- Polyomavirus21 topic
- Soft Tissue Sarcoma21 topic
- Wireless Communication21 topic
Where does Jacques F. Legier work?
Jacques F. Legier's main affiliation in the publication record is Riverside Regional Medical Center, United States.
How many publications and citations does Jacques F. Legier have?
OpenAlex counts 21 works and 638 citations for Jacques F. Legier, an h-index of 14, ranking #2,878,574 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Jacques F. Legier. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.